Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05615948 · ClinicalTrials.gov registry record · Phase 4
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
A Phase 4 study, sponsored by Theresa Jacob, PhD, MPH.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT05615948: Completed Phase 4 study, sponsored by Theresa Jacob, PhD, MPH.
NCT05615948 is a Phase 4 study that has completed, run by Theresa Jacob, PhD, MPH. The registered enrollment target is 15 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05615948, a Phase 4 study, has completed, sponsored by Theresa Jacob, PhD, MPH.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effects of simultaneous administration of oral aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.
Primary Outcome
Montgomery-Asberg Depression Rating Scale has a range from 0 to 60, where the lower score indicates the better health status. Change in mean total Montgomery Asberg Depression Rating Scale (MADRS) score from the baseline (pre-dose day 1 ) and on day 7
Interventions
- DRUG VTS-K
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-12-06 |
| Est. Completion | 2024-05-17 |
| Phase | Phase 4 |
What the finished NCT05615948 record still lists
NCT05615948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which VTS-K is the first listed.
NCT05615948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05615948 about?
NCT05615948 is a clinical study titled "Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression". The purpose of this study is to assess the effects of simultaneous administration of oral aspirin and oral ketamine as a therapeutic for those with Treatment Resistant Depression.
What is the current status of trial NCT05615948?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2022-12-06. Estimated completion is 2024-05-17.
What interventions are being tested in trial NCT05615948?
The interventions under investigation include: VTS-K (DRUG).
Who is sponsoring clinical trial NCT05615948?
This trial is sponsored by Theresa Jacob, PhD, MPH, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05615948's enrollment target sits among peer trials
15 1880th of 2000 higher than 100 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI